Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |